Substantial Impairment of Voriconazole Clearance by High-Dose Meropenem in a Patient With Renal Failure
- PMID: 28505263
- DOI: 10.1093/cid/cix443
Substantial Impairment of Voriconazole Clearance by High-Dose Meropenem in a Patient With Renal Failure
Abstract
A critically ill patient with multiple postoperative infections repeatedly required profound voriconazole dose reductions whenever high-dose meropenem was added. Subsequent in vitro assessment confirmed inhibition of cytochrome P450 (CYP) 2C19 and CYP3A4 by meropenem, suggesting that during meropenem treatment, narrow therapeutic index drugs metabolized by these CYPs require close monitoring.
Keywords: critically ill; cytochrome P450; drug interaction; meropenem; voriconazole.
© The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Comment in
-
Reply to Truffot et al.Clin Infect Dis. 2018 May 2;66(10):1644-1646. doi: 10.1093/cid/cix1099. Clin Infect Dis. 2018. PMID: 29385537 No abstract available.
-
Inhibition of Voriconazole Metabolism by Meropenem: A Role for Inflammation?Clin Infect Dis. 2018 May 2;66(10):1643-1644. doi: 10.1093/cid/cix1092. Clin Infect Dis. 2018. PMID: 29385544 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
